C
Chorokbaem Healthcare Co Ltd
KRX:118000
Chorokbaem Healthcare Co Ltd
KRX:118000
Price:
239
KRW
-1.65%
Market Cap:
₩41.1B
Chorokbaem Healthcare Co Ltd
Research & Development
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Chorokbaem Healthcare Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Chorokbaem Healthcare Co Ltd
KRX:118000
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
W
|
WSI Co Ltd
KOSDAQ:299170
|
Research & Development
-₩653.3m
|
CAGR 3-Years
-86%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
W
|
Wonik Co Ltd
KOSDAQ:032940
|
Research & Development
-₩1.5B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Life Science Co Ltd
KOSDAQ:067630
|
Research & Development
-₩5.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-56%
|
|
|
B
|
BlueMTec Co Ltd
KOSDAQ:439580
|
Research & Development
-₩1.3B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Chorokbaem Healthcare Co Ltd
Glance View
CHOROKBAEM HEALTHCARE Co., Ltd. engages in the manufacture, distribution, and sale of medical devices, and healthcare products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2009-12-30. The firm operates its business through four segments. The Pharmaceutical Business segment is engaged in the distribution of pharmaceutical including capsules and tablets. The Medical Business segment is engaged in the distribution of medical devices and medical supplies. The Living Health Business segment is engaged in the sale of fitness equipment. The Other segment is engaged in the provision of products and services.
Intrinsic Value
215.31
KRW
Overvaluation 10%
C
